BIM
AXN

BlackRock Investment Management’s Aoxing Pharmaceutical Company Inc. AXN Stock Holding History

BlackRock Investment Management’s Portfolio AXN Stock Details AXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-6,847
Closed -$5K – 4194
2016
Q1 		$5K Hold
6,847
– – ﹤0.01% 3838
2015
Q4 		$5K Buy
6,847
+573
+9% +$720 ﹤0.01% 3887
2015
Q3 		$9K Hold
6,274
– – ﹤0.01% 3751
2015
Q2 		$11K Buy
+6,274
New +$11.2K ﹤0.01% 3703

Other funds holding AXN

Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock Investment Management's AXN Position: Q2 2016 in Review

BlackRock Investment Management sold out of Aoxing Pharmaceutical Company Inc. (AXN) in Q2 2016, closing a stake of 6,847 shares — an estimated $5K sold.

BlackRock Investment Management first reported a position in AXN in Q2 2015 and held it in 4 quarters. The position peaked at $11K in Q2 2015. 11 funds tracked by Wall St. Rank hold AXN as of Q2 2016.

  • BlackRock Investment Management reported no remaining Aoxing Pharmaceutical Company Inc. position as of Q2 2016 after selling out during the quarter.
  • BlackRock Investment Management sold 6,847 Aoxing Pharmaceutical Company Inc. shares in Q2 2016, an estimated $5K.
  • BlackRock Investment Management first reported a position in Aoxing Pharmaceutical Company Inc. in Q2 2015 and held it in 4 quarters.
  • BlackRock Investment Management's Aoxing Pharmaceutical Company Inc. position peaked at $11K in Q2 2015.
  • 11 funds tracked by Wall St. Rank held Aoxing Pharmaceutical Company Inc. as of Q2 2016.

Based on BlackRock Investment Management's 13F filing for Q2 2016, filed 10 Aug 2016.